Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum Cipher Pharmaceuticals Inc T.CPH

Alternate Symbol(s):  CPHRF

Healthcare
Cipher Pharmaceuticals Inc. is a Canada-based specialty pharmaceutical company with a diversified portfolio of commercial and early to late-stage products. The Company acquires products that fulfill unmet medical needs, manages the required clinical development and regulatory approval process, and markets those products either directly in Canada or indirectly through partners in Canada, the... see more

TSX:CPH - Post Discussion

Cipher Pharmaceuticals Inc > Fair Value of $14 per share at Peer EV/ Ebitda
View:
Post by nozzpack on Oct 15, 2021 9:18am

Fair Value of $14 per share at Peer EV/ Ebitda

Current EV/Ebitda multiple is 17.22 times..see link below

All Values in C $.

EV = Market cap plius debt less cash =$51 million.

Annual Ebitda - Q2 X 4 X 1.25 =  $4.1 US X 4 x 1.25 = $20.5 in C$.

Fair value Market cap = $20.5  X  17.22  + $19 m cash = $370 million in CAD

Fair value Per share = $370 m / 26.5 m shares = $14 cad

We are grossly under valued..nothing new there..








https://pages.stern.nyu.edu/~adamodar/New_Home_Page/datafile/vebitda.html
Be the first to comment on this post
Cipher Pharmaceuticals Inc